ClearPoint Neuro (CLPT) Short Interest Ratio & Short Volume $12.08 -0.08 (-0.66%) Closing price 05/22/2025 04:00 PM EasternExtended Trading$11.96 -0.13 (-1.03%) As of 07:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ClearPoint Neuro Short Interest DataClearPoint Neuro (CLPT) has a short interest of 1.07 million shares. This marks a 18.89% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.3, indicating that it would take 4.3 days of the average trading volume of 234,940 shares to cover all short positions.Current Short Interest1,070,000 sharesPrevious Short Interest900,000 sharesChange Vs. Previous Month+18.89%Dollar Volume Sold Short$15.40 millionShort Interest Ratio4.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares27,989,000 sharesPercentage of Shares Shorted3.82%Today's Trading Volume165,707 sharesAverage Trading Volume234,940 sharesToday's Volume Vs. Average71% Short Selling ClearPoint Neuro? Sign up to receive the latest short interest report for ClearPoint Neuro and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCLPT Short Interest Over TimeCLPT Days to Cover Over TimeCLPT Percentage of Float Shorted Over Time ClearPoint Neuro Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20251,070,000 shares $15.40 million +18.9%N/A4.3 $14.39 4/15/2025900,000 shares $10.60 million +7.6%3.5%3.7 $11.78 3/31/2025836,800 shares $9.95 million +12.3%3.2%3.4 $11.89 3/15/2025744,900 shares $9.53 million +2.8%2.9%3.2 $12.80 2/28/2025724,800 shares $10.52 million +14.0%2.8%2.9 $14.52 2/15/2025635,700 shares $11.65 million -2.7%2.5%3 $18.32 1/31/2025653,400 shares $11.41 million -22.1%N/A2.8 $17.46 1/15/2025838,600 shares $12.67 million +13.5%N/A3.6 $15.11 12/31/2024739,200 shares $11.37 million -0.7%N/A3.1 $15.38 12/15/2024744,200 shares $11.40 million +1.1%N/A3.3 $15.33 Get the Latest News and Ratings for CLPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ClearPoint Neuro and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024736,200 shares $9.11 million -3.1%N/A3.3 $12.37 11/15/2024759,900 shares $8.31 million +10.5%N/A3.6 $10.93 10/31/2024687,600 shares $8.52 million -3.5%N/A3.3 $12.39 10/15/2024712,200 shares $8.57 million +15.2%N/A3.6 $12.04 9/30/2024618,500 shares $6.93 million -13.8%N/A3.4 $11.21 9/15/2024717,800 shares $9.04 million +1.2%N/A2.9 $12.59 8/31/2024709,400 shares $9.21 million -11.3%N/A3 $12.98 8/15/2024799,700 shares $8.67 million -0.7%N/A3.4 $10.84 7/31/2024805,400 shares $5.77 million -5.9%N/A3.6 $7.16 7/15/2024855,900 shares $6.44 million -37.5%N/A4.1 $7.52 6/30/20241,370,000 shares $7.38 million +9.6%N/A6.7 $5.39 6/15/20241,250,000 shares $6.76 million +4.2%N/A9.1 $5.41 5/31/20241,200,000 shares $6.52 million -6.3%N/A8.3 $5.43 5/15/20241,280,000 shares $8.19 million -5.9%N/A7.8 $6.40 4/30/20241,360,000 shares $7.38 million +10.6%N/A8.7 $5.43 4/15/20241,230,000 shares $6.90 million -3.9%N/A8.2 $5.61 3/31/20241,280,000 shares $8.70 million -8.6%N/A8.4 $6.80 3/15/20241,400,000 shares $10.01 million +0.7%N/A9 $7.15 2/29/20241,390,000 shares $8.88 million -2.8%N/A10.3 $6.39 2/15/20241,430,000 shares $10.65 million +3.6%N/A14.4 $7.45 1/31/20241,380,000 shares $9.60 million +3.8%N/A13.1 $6.96 1/15/20241,330,000 shares $9.54 million No ChangeN/A12.5 $7.17 12/31/20231,330,000 shares $9.03 million -8.3%N/A13.2 $6.79 12/15/20231,450,000 shares $9.03 million -0.7%N/A15.3 $6.23 11/30/20231,460,000 shares $8.41 million +0.7%N/A15.7 $5.76 11/15/20231,450,000 shares $7.16 million +0.7%N/A15.7 $4.94 10/31/20231,440,000 shares $7.92 million No ChangeN/A15.8 $5.50 10/15/20231,440,000 shares $6.67 million +13.4%N/A14.2 $4.63 9/30/20231,270,000 shares $6.36 million -1.6%N/A12.9 $5.01 9/15/20231,290,000 shares $6.63 million +3.2%N/A12.8 $5.14The MAGA 7 Stocks: Huge Upside in 2025 (Ad)The Trump economy is back in full force, and it’s creating huge opportunities for investors. With Trump pushing for lower taxes, fewer regulations, tariffs on foreign competitors, and domestic manufacturing dominance, some stocks are set to skyrocket in value—while others will be left behind. That’s why we put together this free report revealing the 7 MAGA stocks poised to thrive in 2025.🔻 Download the full report now and get the inside track on these 7 powerhouse stocks. 8/31/20231,250,000 shares $7.26 million +10.6%N/A7.9 $5.81 8/15/20231,130,000 shares $6.78 million No ChangeN/A6 $6.00 7/31/20231,130,000 shares $7.76 million -4.2%N/A6.3 $6.87 7/15/20231,180,000 shares $7.76 million +6.3%N/A7 $6.58 6/30/20231,110,000 shares $8.04 million +53.9%N/A6.5 $7.24 6/15/2023721,100 shares $5.02 million +0.6%N/A4.3 $6.96 5/31/2023716,700 shares $5.52 million -1.8%N/A6.8 $7.70 5/15/2023729,700 shares $6.54 million +2.5%N/A9.7 $8.96 4/30/2023712,200 shares $7.49 million -6.4%N/A10.1 $10.52 4/15/2023760,700 shares $8.04 million +1.1%N/A10.3 $10.57 3/31/2023752,600 shares $6.35 million +6.6%N/A10.6 $8.44 3/15/2023706,000 shares $5.37 million -2.1%N/A9.9 $7.61 2/28/2023720,900 shares $6.11 million +0.5%N/A10.3 $8.48 2/15/2023717,000 shares $6.52 million -2.2%N/A10.3 $9.10 1/31/2023733,200 shares $6.97 million -5.7%N/A9.6 $9.51 1/15/2023777,600 shares $8.27 million -1.3%N/A9.9 $10.63 12/30/2022788,100 shares $6.68 million -1.3%N/A9.5 $8.47 12/15/2022798,600 shares $6.57 million +1.1%N/A9.3 $8.23 11/30/2022790,100 shares $7.45 million -3.3%N/A8.6 $9.43 11/15/2022816,700 shares $8.26 million -2.0%N/A8.6 $10.11 10/31/2022833,200 shares $8.34 million -3.4%N/A7.5 $10.01 10/15/2022862,300 shares $8.31 million -6.0%N/A7.4 $9.64 9/30/2022917,100 shares $9.50 million -1.9%N/A7.7 $10.36 9/15/2022934,400 shares $11.07 million +0.5%N/A5.5 $11.85 8/31/2022930,200 shares $11.97 million -12.3%N/A5.3 $12.87 8/15/20221,060,000 shares $16.98 million -15.2%N/A5.5 $16.02 7/31/20221,250,000 shares $17.71 million -3.1%6.6%6 $14.17 7/15/20221,290,000 shares $16.43 million -3.7%7.0%5.8 $12.74 6/30/20221,340,000 shares $17.49 million -28.0%7.2%5.7 $13.05 6/15/20221,860,000 shares $19.21 million +2.2%10.0%8 $10.33 5/31/20221,820,000 shares $19.95 million +0.6%9.8%9.2 $10.96 5/15/20221,810,000 shares $15.48 million +24.8%9.7%8.6 $8.55 4/30/20221,450,000 shares $12.43 million +2.8%7.8%7.2 $8.57 4/15/20221,410,000 shares $16.07 million +3.7%7.6%6.3 $11.40 3/31/20221,360,000 shares $14.16 million No Change7.3%6 $10.41 3/15/20221,360,000 shares $10.93 million +3.0%7.3%5.7 $8.04 2/28/20221,320,000 shares $11.55 million +20.0%7.1%5.1 $8.75 2/15/20221,100,000 shares $9.19 million +14.6%5.9%4.1 $8.35 1/31/2022959,600 shares $8.47 million +21.9%5.2%3.3 $8.83 1/15/2022787,400 shares $7.76 million +8.9%N/A2.8 $9.85 12/31/2021723,000 shares $8.11 million -7.4%3.8%2.7 $11.22 12/15/2021780,400 shares $9.08 million +18.4%4.1%3.1 $11.64 11/30/2021659,300 shares $9.05 million +1.0%3.5%2.9 $13.73 11/15/2021653,000 shares $10.39 million -15.1%3.5%3 $15.91 10/29/2021769,300 shares $12.87 million -4.2%4.4%3.5 $16.73 10/15/2021803,000 shares $14.42 million -6.6%4.6%3.4 $17.96 9/30/2021859,600 shares $15.26 million -6.6%4.9%3.3 $17.75 9/15/2021920,600 shares $16.55 million +7.4%5.2%2.7 $17.98 8/31/2021857,400 shares $16.18 million -38.8%5.0%2.4 $18.87 8/13/20211,400,000 shares $24.78 million +10.2%8.1%3.6 $17.70[INSIDE] Elon’s Next Move Could Send This AI Stock Soaring (Ad)Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.Reserve your spot before it's gone >>> 7/30/20211,270,000 shares $28.23 million +11.4%7.9%3.4 $22.23 7/15/20211,140,000 shares $19.07 million +38.2%7.1%3.2 $16.73 6/30/2021825,000 shares $15.75 million +70.4%5.1%2.2 $19.09 6/15/2021484,100 shares $9.35 million -13.0%3.0%1.4 $19.32 5/28/2021556,200 shares $10.25 million +13.6%3.3%1.5 $18.42 5/14/2021489,600 shares $8.54 million -5.6%2.9%1.1 $17.45 4/30/2021518,400 shares $10.99 million +28.8%3.1%1.1 $21.20 4/15/2021402,600 shares $8.37 million +23.9%2.4%0.8 $20.80 3/31/2021324,900 shares $6.36 million +3.6%2.0%0.7 $19.58 3/15/2021313,600 shares $6.35 million +63.0%1.9%0.7 $20.25 2/26/2021192,400 shares $4.16 million -2.9%1.2%0.5 $21.64 2/12/2021198,100 shares $5.04 million -45.1%1.4%0.6 $25.44 1/29/2021360,800 shares $8.76 million +31.3%2.8%1.5 $24.27 1/15/2021274,800 shares $4.33 million No Change2.1%1.2 $15.76 CLPT Short Interest - Frequently Asked Questions What is ClearPoint Neuro's current short interest? Short interest is the volume of ClearPoint Neuro shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 1,070,000 shares of CLPT short. Learn More on ClearPoint Neuro's current short interest. What is a good short interest ratio for ClearPoint Neuro? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLPT shares currently have a short interest ratio of 4.0. Learn More on ClearPoint Neuro's short interest ratio. Which institutional investors are shorting ClearPoint Neuro? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ClearPoint Neuro: PEAK6 LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ClearPoint Neuro's short interest increasing or decreasing? ClearPoint Neuro saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,070,000 shares, an increase of 18.9% from the previous total of 900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ClearPoint Neuro's short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to ClearPoint Neuro: National Vision Holdings, Inc. (9.70%), Cadre Holdings, Inc. (7.50%), Liquidia Co. (15.84%), Artivion, Inc. (9.07%), BioLife Solutions, Inc. (8.29%), Pulse Biosciences, Inc. (18.95%), Paragon 28, Inc. (2.22%), MiMedx Group, Inc. (3.24%), InMode Ltd. (9.50%), Establishment Labs Holdings Inc. (16.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short ClearPoint Neuro stock? Short selling CLPT is an investing strategy that aims to generate trading profit from ClearPoint Neuro as its price is falling. CLPT shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ClearPoint Neuro? A short squeeze for ClearPoint Neuro occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLPT, which in turn drives the price of the stock up even further. How often is ClearPoint Neuro's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLPT, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies National Vision Short Squeeze Cadre Short Squeeze Liquidia Short Squeeze Artivion Short Squeeze BioLife Solutions Short Squeeze Pulse Biosciences Short Squeeze Paragon 28 Short Squeeze MiMedx Group Short Squeeze InMode Short Squeeze Establishment Labs Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLPT) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredSilver Is the New Oil—And the World’s Running DryElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLPT Stock Free CLPT Stock Alerts